Literature DB >> 23584976

Impact of physiochemical properties on pharmacokinetics of protein therapeutics.

Rajan Swami1, Aliasgar Shahiwala.   

Abstract

Physicochemical properties, such as molecular weight, size, partition coefficient, acid dissociation constant and solubility have a great impact on pharmacokinetics of traditional small molecule drugs and substantially used in development of small drugs. However, predicting pharmacokinetic fate (absorption, distribution, metabolism and elimination) of protein therapeutics from their physicochemical parameters is extremely difficult due to the macromolecular nature of therapeutic proteins and peptides. Their structural complexity and immunogenicity are other contributing factors that determine their biological fate. Therefore, to develop generalized strategies concerning development of therapeutic proteins and peptides are highly challenging. However, reviewing the literature, authors found that physiochemical properties, such as molecular weight, charge and structural modification are having great impact on pharmacokinetics of protein therapeutics and an attempt is made to provide the major findings in this manuscript. This manuscript will serve to provide some bases for developing protein therapeutics with desired pharmacokinetic profile.

Mesh:

Substances:

Year:  2013        PMID: 23584976     DOI: 10.1007/s13318-013-0126-0

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  99 in total

1.  Pharmacokinetics of several subcutaneous doses of erythropoietin: potential implications for blood transfusion.

Authors:  T Sans; J Joven; E Vilella; G Masdeu; M Farrè
Journal:  Clin Exp Pharmacol Physiol       Date:  2000-03       Impact factor: 2.557

Review 2.  The role of glycosylation in protein antigenic properties.

Authors:  E Lisowska
Journal:  Cell Mol Life Sci       Date:  2002-03       Impact factor: 9.261

Review 3.  Preformulation studies as an essential guide to formulation development and manufacture of protein pharmaceuticals.

Authors:  David B Volkin; Gautam Sanyal; Carl J Burke; C Russell Middaugh
Journal:  Pharm Biotechnol       Date:  2002

Review 4.  Pharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins.

Authors:  Iftekhar Mahmood; Martin D Green
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

5.  PEGylation improves pharmacokinetic profile, liver uptake and efficacy of Interferon gamma in liver fibrosis.

Authors:  Ruchi Bansal; Eduard Post; Johannes H Proost; Alie de Jager-Krikken; Klaas Poelstra; Jai Prakash
Journal:  J Control Release       Date:  2011-06-12       Impact factor: 9.776

6.  Studies on renal tubular protein reabsorption: partial and near complete inhibition by certain amino acids.

Authors:  C E Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1977-10       Impact factor: 1.713

7.  Ocular membrane permeability of hydrophilic drugs for ocular peptide delivery.

Authors:  H Sasaki; M Ichikawa; K Yamamura; K Nishida; J Nakamura
Journal:  J Pharm Pharmacol       Date:  1997-02       Impact factor: 3.765

8.  GlycoPEGylation of recombinant therapeutic proteins produced in Escherichia coli.

Authors:  Shawn DeFrees; Zhi-Guang Wang; Ruye Xing; Arthur E Scott; Jin Wang; David Zopf; Dominique L Gouty; Eric R Sjoberg; Krishnasamy Panneerselvam; Els C M Brinkman-Van der Linden; Robert J Bayer; Mads A Tarp; Henrik Clausen
Journal:  Glycobiology       Date:  2006-05-22       Impact factor: 4.313

9.  Relationship between pharmacokinetic profile of subcutaneously administered alemtuzumab and clinical response in patients with chronic lymphocytic leukemia.

Authors:  Michela Montagna; Marco Montillo; Maria A Avanzini; Carmine Tinelli; Alessandra Tedeschi; Livia Visai; Francesca Ricci; Eleonora Vismara; Enrica Morra; Mario Regazzi
Journal:  Haematologica       Date:  2011-02-17       Impact factor: 9.941

10.  Glycodermorphins: opioid peptides with potent and prolonged analgesic activity and enhanced blood-brain barrier penetration.

Authors:  L Negri; R Lattanzi; F Tabacco; B Scolaro; R Rocchi
Journal:  Br J Pharmacol       Date:  1998-08       Impact factor: 8.739

View more
  2 in total

Review 1.  Ocular delivery of proteins and peptides: Challenges and novel formulation approaches.

Authors:  Abhirup Mandal; Dhananjay Pal; Vibhuti Agrahari; Hoang My Trinh; Mary Joseph; Ashim K Mitra
Journal:  Adv Drug Deliv Rev       Date:  2018-01-13       Impact factor: 15.470

Review 2.  Advanced delivery strategies facilitating oral absorption of heparins.

Authors:  Guihua Fang; Bo Tang
Journal:  Asian J Pharm Sci       Date:  2020-01-09       Impact factor: 6.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.